Life Lua Wins Fierce Biotech Innovation Award

Life Lua, the developer of a HIPAA-compliant web and mobile access technology platform, has been named winner of a 2018 Fierce Innovation Award, Life Sciences Edition, in the Digital Health Solutions Category.

Each year, Fierce Biotech recognizes companies that have gone the extra mile and are conducting leading-edge work in the field of health and biotechnology. On December 13, 2018, Rebecca Willumson, publisher of Fierce Biotech, confirmed Life Lua Technologies had been named category winner.

Life Lua Technologies, a subsidiary of Life Biosciences Inc, has developed a mobile-first communications platform for the healthcare industry that allows healthcare professionals to communicate efficiently and effectively, no matter where they are located. The platform supports voice and video calls, file sharing, and promotes collaboration with all members of the care team to ensure the best possible care can be provided to patients.

The platform also incorporates leading security protections to ensure all protected health information collected, maintained, stored, or transmitted through the platform is safeguarded to standards in excess of those required by HIPAA. The platform helps healthcare providers communicate more efficiently and effectively, improve communication workflow, cut costs, strengthen care coordination, and improve the patient experience.

“Fierce Biotech has recognized the remarkable significance of Lua’s innovative platform,” said Tristan Edwards, co-founder and chief executive officer of Life Biosciences.  “Direct-to-patient, secure video and messaging allows for the delivery of simple services in an efficient way, like sharing a patient’s results or discussing their known, recurrent issues. That’s real innovation. We couldn’t be more proud and thrilled.”

“We are thrilled by Fierce Biotech’s recognition of our leading-edge work,” added Michael DeFranco, chief executive officer of Life Lua.

Author: Steve Alder has many years of experience as a journalist, and comes from a background in market research. He is a specialist on legal and regulatory affairs, and has several years of experience writing about HIPAA. Steve holds a B.Sc. from the University of Liverpool.